M
Mark A. Schuster
Researcher at Kaiser Permanente
Publications - 382
Citations - 20061
Mark A. Schuster is an academic researcher from Kaiser Permanente. The author has contributed to research in topics: Health care & Adolescent health. The author has an hindex of 68, co-authored 374 publications receiving 18154 citations. Previous affiliations of Mark A. Schuster include Los Angeles County Department of Public Health & University of Pennsylvania.
Papers
More filters
Journal ArticleDOI
A national survey of stress reactions after the September 11, 2001, terrorist attacks.
Mark A. Schuster,Bradley D. Stein,Lisa H. Jaycox,Rebecca L. Collins,Grant N. Marshall,Marc N. Elliott,Annie Jie Zhou,David E. Kanouse,Janina L. Morrison,Sandra H. Berry +9 more
TL;DR: After the September 11 terrorist attacks, Americans across the country, including children, had substantial symptoms of stress, and clinicians who practice in regions that are far from the recent attacks should be prepared to assist people with trauma-related Symptoms of stress.
Journal ArticleDOI
Bullying Among Young Adolescents: The Strong, the Weak, and the Troubled
TL;DR: Bully-victims were the most troubled group, displaying the highest level of conduct, school, and peer relationship problems, and pediatricians can recommend school-wide antibullying approaches that aim to change peer dynamics that support and maintain bullying.
Journal ArticleDOI
How Good Is the Quality of Health Care in the United States
TL;DR: Efforts to measure quality and report routinely on the results to the public at large would allow more definitive assessments of the status of the nation's health care and would enable us to single out the areas in need of improvement.
Journal ArticleDOI
The Quality of Ambulatory Care Delivered to Children in the United States
Rita Mangione-Smith,Alison H. DeCristofaro,Claude Messan Setodji,Joan Keesey,David J. Klein,John L. Adams,Mark A. Schuster,Elizabeth A. McGlynn +7 more
TL;DR: Deficits in the quality of care provided to children appear to be similar in magnitude to those previously reported for adults and strategies to reduce these apparent deficits are needed.
Journal ArticleDOI
Posaconazole as salvage therapy for zygomycosis
Richard N. Greenberg,Richard N. Greenberg,Kathleen M. Mullane,J. A H Van Burik,Issam I Raad,Mark J. Abzug,Gregory M. Anstead,Raoul Herbrecht,Amelia Langston,Kieren A. Marr,Gary J. Schiller,Mark A. Schuster,John R. Wingard,C. E. Gonzalez,Sanjay G. Revankar,G. Corcoran,Richard J. Kryscio,R. S. Hare +17 more
TL;DR: Posaconazole appears promising as an oral therapy for zygomycosis in patients who receive required surgery and control their underlying illness, and was well tolerated and was discontinued in only one subject due to a drug rash.